John B. Moriarty, SVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,036 shares at $155.55 ($161K) on 2014-02-07, disclosed to the SEC on 2014-02-10.
Open-market sale of $161k ALXN by SVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.55 | 1,020 | $159K | 98.4% |
| 2 | $158.56 | 16 | $3K | 1.6% |
| Total | $155.60 avg | 1,036 | $161K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |